Exposure and Dosimetry Considerations for Adverse Outcome Pathways

2017-06-30T13:51:46Z (GMT) by John Wambaugh 0000-0002-4024-534X
Presented at the Application of New Methods in Risk Science in Regulatory Decision-Making Regarding Chemical Substances